Table 3.
Serum ceruloplasmin levels in WD patients and non-WD diseases
| Group | Cp (mg/dL) | No. of patients | p value | |||||
|---|---|---|---|---|---|---|---|---|
| Total | 0–5 | 5–10 | 10–15 | 15–20 | ≥ 20 | |||
| Healthy children | 30.7 ± 7.8 | 372 | 0 | 3 | 10 | 17 | 342 | |
| WD patients | 5.7 ± 4.7 | 317 | 184 | 78 | 36 | 13 | 6 | *p < 0.001 |
| Non-WD ALF | 27.4 ± 12.7 | 20 | 0 | 0 | 3 | 3 | 14 | *p > 0.05 |
| Viral hepatitis | 32.5 ± 7.9 | 38 | 0 | 0 | 1 | 2 | 35 | *p > 0.05 |
| Nephrotic syndrome | 26.1 ± 9.0 | 96 | 0 | 0 | 7 | 13 | 76 | *p < 0.001 |
| Total | 27.8 ± 9.7 | 154 | 0 | 0 | 11 | 18 | 125 | |
WD, Wilson’s disease; Cp, ceruloplasmin; ALF, acute liver failure
*p value while compared with healthy control